Agios Pharmaceuticals reported U$-91 million in Net Income for its second quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie U$ -738M 3748M
Acceleron Pharma U$ -19M 32M
Agios Pharmaceuticals U$ -91M 50M
Alexion Pharmaceuticals U$ -1068.1M 1625.7M
Alnylam Pharmaceuticals U$ -180M 3M
Amgen U$ 1803M 22M
AstraZeneca 756M 24M
Bayer € -9548M 11037M
Biogen U$ 701.5M 840.6M
Biomarin Pharmaceutical U$ -29.183M 110.564M
Bluebird Bio U$ -21.465M 181.146M
Bristol Myers Squibb U$ -85M 690M
Daiichi Sankyo Y 31857M 37063M
Eli Lilly And U$ 1412M 44.5M
Exelixis U$ 66M 18M
Gilead Sciences U$ -3339M 4890M
GlaxoSmithKline 2263M 698M
Immunogen U$ -24.298M 4.79M
JAZZ PHA U$ 148.234M 33.433M
Merk U$ 3002M 217M
Novartis U$ 1935M 68M
Pfizer U$ 3426M 25M
Puma Biotechnology U$ 3M 20M
Regeneron Pharmaceuticals U$ 897.3M 272.7M
Sarepta Therapeutics U$ -151M 133M
Seattle Genetics U$ -21.19M 147.212M
Vertex Pharmaceuticals U$ 837.27M 234.517M
YTE U$ 290.298M 1010.94M